Transcranial and Rapid Magnetic Stimulation for Gait Apraxia Due to Normal Pressure Hydrocephalus and Cerebral Ischemia

Sponsor
Devathasan Neurology Practice Pte Ltd (Other)
Overall Status
Unknown status
CT.gov ID
NCT00494689
Collaborator
(none)
30
2
65
15
0.2

Study Details

Study Description

Brief Summary

The investigator(neurologist) has published a study in International Congress Series, in the 15th International Conference of Biomagnetism Vancouver Proceedings 2006,and Science Direct website, of 15 patients with brain ischemia and dilated ventricles who improve when treated with transcranial monitoring or low ultrasound wave intensity (milliwatts) and with rapid magnetic stimulation which is also a diagnostic tool routinely used by many neurophysiologists. Before, these patients will progress and may need a brain shunt called Ventriculo-peritoneal shunt. He and collaborators now would like to do a double study as this appears to be a cheap and effective alternative treatment and help patients to walk again.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The transcranial monitoring intensity would be equivalent to the well known CLOTBUST study (<300mw/sq cm)for one hour, using two probes.

    All will be treated as an outpatient and there is no form of infusion or interventional treatment.

    The rapid magnetic stimulation is at about 50a/us, 15Hz, 1000 pulses with 10 sec pause for ten days along the skull vault. Informed consent will be obtained. 30 patients will be recruited and sham treatment would be just applying probe without power for transcranial and for magnetic stimulation coil will be angled away. Data will be compiled by a separate blinded investigator and so with the statistics. VP shunt failure patients, which is common, will be included. Barthel's daily living index and standard cognitive tests will be used to assess results.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Study Start Date :
    Jan 1, 2002
    Anticipated Study Completion Date :
    Jun 1, 2007

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      N/A and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • cerebral ischemia with our without hydrocephalus and gait apraxia
      Exclusion Criteria:
      • all other conditions which contribute to walking difficulty e.g. bad knees; or spondylosis; parkinson's or paralytic strokes

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Devathasan Neurology Practice #11-16 MEMC Singapore Singapore 228510
      2 Devathasan Neurology Practice Singapore Singapore 228510

      Sponsors and Collaborators

      • Devathasan Neurology Practice Pte Ltd

      Investigators

      • Study Chair: Weng Kiong Aw Yong, Bsc (QUT), Freelancer Computer Programmer and data control

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00494689
      Other Study ID Numbers:
      • 02
      First Posted:
      Jul 2, 2007
      Last Update Posted:
      Jul 2, 2007
      Last Verified:
      Jun 1, 2007

      Study Results

      No Results Posted as of Jul 2, 2007